10-KFiled 18 Sep 2026Software / SaaS
Nutanix, Inc.NTNX
Annual report (10-K), FY2026
No notable change in AIR's read.
The nightly ledger
Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.
By event type: Acquisitions · Major contracts
Seven-day window, 9 weeks back · Material filings: 55 · All filings: 254
Friday 18 Sep26 filings read · 6 material
10-KFiled 18 Sep 2026Software / SaaS
Nutanix, Inc.NTNX
Annual report (10-K), FY2026
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
8-K · Items 1.01, 5.02, 8.01 — Material agreement
Mistras Group agreed to be acquired by H.I.G. Capital-affiliated funds for $20.35/share cash. Board unanimously approved. Transaction subject to stockholder vote, regulatory approvals, and customary closing conditions. 40-day go-shop period permitted.
No notable change in AIR's read.
8-KFiled 18 Sep 2026Banks
8-K · Item 1.01 — Material agreement
Credit Acceptance settled multi-state attorney general investigation with $15.5M penalty, $60M consumer remediation trust, and ~$634M debt relief to customers. Company must implement 5-7 year operational and disclosure requirements. No admission of wrongdoing.
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
8-K · Item 1.01 — Material agreement
Beazer Homes obtained bondholder consents to amend Change of Control definitions in senior notes (2031 and 2032) so the pending Dream Finders merger will not trigger change-of-control provisions. Amendments become operative upon consent fee payment at merger close.
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
8-K · Items 1.01, 1.02, 2.03, 3.03 — Material agreement
Hecla Mining entered into a new $500M senior secured revolving credit facility maturing September 2030, replacing its existing July 2022 credit agreement. The new facility has less restrictive collateral requirements (equity pledges only vs. mortgage on Greens Creek mine).
No notable change in AIR's read.
8-KFiled 18 Sep 2026Industrials
Evolution Metals & Technologies Corp.EMAT
8-K · Items 1.01, 2.03, 3.02 — Material agreement
EMAT raised $30.9M in convertible debentures from Yorkville with conversion at 95% of 5-day VWAP (floor at $5.02). Debentures mature in 2 years; 4% interest rising to 18% on default. Significant dilution risk and amortization triggers if stock falls below floor or 99% of Exchange Cap is used.
No notable change in AIR's read.
Thursday 17 Sep54 filings read · 10 material
8-KFiled 17 Sep 2026All industries
8-K · Item 2.01 — Acquisition or disposal of assets
Surgery Partners completed sale of Idaho Falls hospital facilities to Intermountain Health for $797M gross proceeds ($587M net). Proceeds will reduce debt leverage by 30bps and streamline portfolio toward pure-play surgical provider model with improved operational metrics.
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
8-K · Items 1.01, 2.03 — Material agreement
Enova's subsidiary amended its $535M securitization facility with extended revolving period to March 2028 and maturity to March 2029. Terms include Class A loans at SOFR+2.75% and Class B at SOFR+8.50%.
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
Piedmont Realty Trust, Inc.PDM
8-K · Items 1.01, 2.03, 3.02 — Material agreement
PDM issued $230M of 2.875% exchangeable senior notes due 2031, with $30M option notes exercised. Proceeds will redeem higher-cost 9.250% notes due 2028, reducing interest expense. Company also repurchased ~5.4M shares concurrently.
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
8-K · Items 1.01, 2.03 — Material agreement
Burford issued $300M of 8.0% senior secured notes due 2029 to refinance existing 6.25% notes due 2028. The higher coupon rate and extended maturity increase debt service costs and financial obligations.
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
8-K · Items 1.01, 2.03, 8.01 — Material agreement
EFC issued $150M in 7.375% unsecured senior notes due 2030 in a private offering. Proceeds will be used for general corporate purposes, including repaying repurchase agreement borrowings and funding asset purchases.
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
8-K · Items 1.01, 2.03, 8.01 — Material agreement
Amerant Bancorp completed a $50M senior notes offering at 7.00% due 2031, netting ~$48.4M. Proceeds designated for general corporate purposes including organic growth, debt repayment, and share repurchases.
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
Bank7 Corp.BSVN
8-K · Item 1.01 — Material agreement
Bank7 Corp. entered into definitive merger agreement to acquire Century Financial Services Corporation for ~$137.3M ($70M cash + 1.23M shares). Combined entity will have ~$3.3B assets, expanding into New Mexico market with Century's $1.2B legacy deposit base.
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
8-K · Items 1.01, 2.03 — Material agreement
Hallador closed a $600M senior secured term loan facility ($550M funded at closing, $50M delayed draw) plus up to $75M revolving credit to fund the Turtle Creek 460-MW natural gas project (sub-$800M cost). Financing covers majority of capital needs; company expects to refinance post-commercial operation.
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
Rexford Industrial Realty, Inc.REXR
8-K · Item 2.01 — Acquisition or disposal of assets
Rexford Industrial completed a $1.2 billion sale of 22 industrial properties to EQT Real Estate affiliate, advancing its $2.0 billion non-core portfolio realignment. Year-to-date dispositions total $1.5 billion. Proceeds deployed toward debt repayment, stock repurchases, and development projects.
No notable change in AIR's read.
8-KFiled 17 Sep 2026Software / SaaS
8-K · Items 1.01, 2.03 — Material agreement
Paylocity amended and restated its revolving credit agreement with PNC Bank, replacing the 2019 facility. The new $1.75B facility matures in 2031 with $81.25M drawn at signing. Terms include standard covenants and pricing tied to leverage ratios.
No notable change in AIR's read.
Wednesday 16 Sep44 filings read · 8 material
8-KFiled 16 Sep 2026Industrials
8-K · Items 1.01, 3.02 — Material agreement
Generac entered a long-term supply agreement with Amazon, issuing a warrant for up to 1.69M shares at $200.93/share. Initial deliveries expected to total $2.4B in 2027–2028, with vesting contingent on up to $8B in aggregate payments for backup generators for Amazon data centers.
No notable change in AIR's read.
8-KFiled 16 Sep 2026Industrials
8-K · Items 1.01, 1.02, 3.03 — Material agreement
Sturm Ruger terminated its shareholder rights plan effective immediately, accelerating expiration from October 13 to September 16, 2026. This follows satisfaction of regulatory conditions under a Strategic Cooperation Agreement with Beretta Holding announced in May.
No notable change in AIR's read.
8-KFiled 16 Sep 2026Software / SaaS
Cyberloq Technologies, Inc.ACRT
8-K · Item 1.01 — Material agreement
Company restructured convertible debt by consolidating notes, eliminating interest through 2028, converting prior accrued interest to equity at $0.10/share, and amending articles to create Class B non-voting shares.
No notable change in AIR's read.
8-KFiled 16 Sep 2026All industries
8-K · Item 1.01 — Material agreement
ChronoScale extended maturity of $2.0M term loan from September 2026 to November 2026 and permitted sale of subsidiary. Extension suggests difficulty meeting original obligations and potential distress.
No notable change in AIR's read.
8-KFiled 16 Sep 2026All industries
Oaktree Specialty Lending CorpOCSL
8-K · Item 1.01 — Material agreement
OCSL issued $300M of 7.000% unsecured notes due 2031. Proceeds will reduce senior secured revolving credit facility debt and fund general corporate purposes, including potential repayment of 2027 notes at maturity.
No notable change in AIR's read.
8-KFiled 16 Sep 2026All industries
8-K · Item 2.01 — Acquisition or disposal of assets
BrightSpire completed sale of two industrial net-lease properties (Arizona, California) for $300M gross consideration on September 14, 2026. Transaction generated approximately $60.4M estimated gain and $97.9M net cash proceeds after debt assumption.
No notable change in AIR's read.
8-KFiled 16 Sep 2026Industrials
8-K · Item 1.01 — Material agreement
Mercury Systems extended CEO William L. Ballhaus's employment agreement through August 15, 2030. The company reaffirmed prior financial guidance issued on August 18, 2026. No material business changes disclosed.
No notable change in AIR's read.
8-KFiled 16 Sep 2026All industries
Essential Properties Realty Trust, Inc.EPRT
8-K · Items 1.01, 1.02, 2.03 — Material agreement
EPRT amended its credit agreement, increasing revolving facility from $1.0B to $1.3B, reducing pricing margins, releasing subsidiary guarantors, and repaying/terminating a Capital One facility.
No notable change in AIR's read.
Tuesday 15 Sep67 filings read · 13 material
8-KFiled 15 Sep 2026Software / SaaS
Healthstream IncHSTM
8-K · Items 1.01, 3.02 — Material agreement
HealthStream raised $40.0M via issuance of 1.36M shares at $29.50/share to WJRJJ Ventures. CEO Frist sold 144K shares. Investor has 42% stake in Empath Nursing, with which HealthStream has a strategic partnership. Proceeds for general corporate purposes and potential acquisitions.
No notable change in AIR's read.
8-KFiled 15 Sep 2026All industries
8-K · Item 2.02 — Results of operations
Q1 FY2027 net income surged 1530% to $16.3M; diluted EPS up 900% to $0.10. Company completed transformational Sweetwater acquisition, becoming largest U.S. non-precious metal royalty platform with 5.3M acres. Uranium counterparties maintained production guidance.
No notable change in AIR's read.
8-KFiled 15 Sep 2026Software / SaaS
8-K · Items 1.01, 1.02, 2.03, 3.02, 8.01 — Material agreement
Tenable completed an $800M convertible notes offering (upsized from $650M), generating ~$779M net proceeds. Funds used to repay term loans, repurchase $170.5M stock, and fund capped call transactions. Provides financial flexibility for acquisitions and strategic investments.
No notable change in AIR's read.
8-KFiled 15 Sep 2026All industries
8-K · Items 1.01, 2.03 — Material agreement
Capital Southwest Corporation issued $350M in 6.750% unsecured notes due 2031, netting ~$342.1M after fees. Proceeds will repay a portion of the senior secured revolving credit facility. Standard debt capital raise with no stated business impact.
No notable change in AIR's read.
8-KFiled 15 Sep 2026All industries
8-K · Items 1.01, 2.03, 8.01 — Material agreement
ARCC issued $750M of 6.250% unsecured notes due 2033. Proceeds will repay existing credit facility debt; company may reborrow for general corporate purposes and portfolio investments. Interest rate swap entered to convert fixed to floating rate.
No notable change in AIR's read.
8-KFiled 15 Sep 2026Banks
8-K · Items 1.01, 2.03 — Material agreement
WD amended its Master Repurchase Agreement with JPMorgan Chase Bank, extending the termination date to September 9, 2027. This is the ninth amendment to the facility since 2019, with terms detailed in an updated side letter.
No notable change in AIR's read.
8-KFiled 15 Sep 2026All industries
8-K · Items 1.01, 2.03 — Material agreement
Calumet increased its credit facility commitments from $500M to $600M via the Eleventh Amendment to its Credit Agreement, effective September 11, 2026. Related monetization agreement amended to accommodate the expansion.
No notable change in AIR's read.
8-KFiled 15 Sep 2026Banks
Hyperliquid Strategies IncPURR
8-K · Item 1.01 — Material agreement
Company amended its equity purchase agreement with Chardan Capital Markets, reducing per-share pricing to 98.5% and 97.0% of VWAP for future share sales after 160M shares sold. This represents dilution and weaker pricing terms.
No notable change in AIR's read.
8-KFiled 15 Sep 2026All industries
Blue Owl Technology Finance Corp.OTF
8-K · Items 1.01, 2.03 — Material agreement
Athena Funding III LLC (Blue Owl subsidiary) amended its loan facility, increasing maximum principal from $150M to $250M and modifying borrowing base conditions. Expansion signals lender confidence and increased capital availability.
No notable change in AIR's read.
8-KFiled 15 Sep 2026Semiconductors
Applied Optoelectronics, Inc.AAOI
8-K · Items 1.01, 2.03 — Material agreement
Applied Optoelectronics' subsidiary Global Technology leased a 38,312 sq meter manufacturing facility in Ningbo, China for 10 years at RMB 6.9M annual rent, with 3% increases every three years and tenant protections including right of first refusal.
No notable change in AIR's read.
8-KFiled 15 Sep 2026All industries
Iridium Communications Inc.IRDM
8-K · Item 1.01 — Material agreement
Iridium amended its credit agreement with lenders to permit the pending Rocket Lab merger to proceed without triggering a change-of-control clause. Post-closing, interest rates will increase and prepayment/exit fees will apply.
No notable change in AIR's read.
8-KFiled 15 Sep 2026All industries
Lindblad Expeditions Holdings, Inc.LIND
8-K · Item 1.01 — Material agreement
Lindblad acquired 60% controlling interest in Antarctic expedition and aviation companies (White Desert Ltd, PNR Airways Ltd, Echo Charlie Ltd) for ~$61M cash plus ~$6M for balance sheet cash, with options to acquire remaining equity by 2031.
No notable change in AIR's read.
8-KFiled 15 Sep 2026Biotech
8-K · Items 1.01, 1.02 — Material agreement
Pulse Biosciences entered into a new $85M equity distribution agreement with Mizuho, replacing a prior $75M agreement with TD Cowen. The company has already sold ~$68.8M under the August 2026 agreement, indicating ongoing dilution and capital needs.
No notable change in AIR's read.
Monday 14 Sep63 filings read · 18 material
8-KFiled 14 Sep 2026Industrials
Ondas Inc.ONDS
8-K · Items 1.01, 2.01, 3.02, 8.01 — Material agreement
Ondas acquired GATE Technologies and Bron Technologies for $205M upfront plus up to $185M earn-out. GATE develops electronic safe-and-arm devices and fuzing technology for missiles, rockets, UAVs and loitering munitions. Expected to generate $130M+ Adjusted EBITDA through 2028.
No notable change in AIR's read.
10-QFiled 14 Sep 2026Industrials
Quarterly report (10-Q), period ending 31 Jul 2026
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
8-K · Item 1.01 — Material agreement
Perdoceo signed definitive agreement to acquire South University for ~$130–150M upfront plus $18M deferred and up to $56M earn-out. South generated ~$291M revenue and $34M adjusted operating income in 2025 with ~10,500 students. Expected close April 2027; transaction expected immediately accretive to adjusted operating income in 2027.
No notable change in AIR's read.
8-KFiled 14 Sep 2026Banks
Hyperliquid Strategies IncPURR
8-K · Item 1.01 — Material agreement
Company amended its ChEF Purchase Agreement with Chardan Capital Markets, adjusting VWAP-based pricing terms for potential future share sales. VWAP Purchase price set at 98.5% of VWAP; Off-Hour VWAP Purchase at 97.0%.
No notable change in AIR's read.
8-KFiled 14 Sep 2026Industrials
Kestra Medical Technologies, Ltd.KMTS
8-K · Item 2.02 — Results of operations
Kestra reported Q1 FY2027 revenue of $31.0M (+60% YoY) with gross margin expansion to 56.5% from 45.7%. FY27 revenue guidance raised to $141M (+48% growth). Strong execution on WCD market expansion and commercial initiatives.
No notable change in AIR's read.
10-QFiled 14 Sep 2026All industries
Quarterly report (10-Q), period ending 31 Jul 2026
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
Odyssey Marine Exploration IncOMEX
8-K · Items 1.01, 2.03 — Material agreement
No notable change in AIR's read.
10-QFiled 14 Sep 2026Industrials
Kestra Medical Technologies, Ltd.KMTS
Quarterly report (10-Q), period ending 31 Jul 2026
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
CubeSmartCUBE
8-K · Item 2.02 — Results of operations
CubeSmart filed an 8-K furnishing a September 2026 investor presentation. The document provides corporate overview, historical performance metrics, portfolio composition, operational strategies, and governance practices. No material business developments, earnings results, or operational changes are disclosed.
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
Veracyte, Inc.VCYT
8-K · Items 1.01, 2.01 — Material agreement
Veracyte completed acquisition of Convergent Genomics for $150M upfront plus up to $30M in milestone payments. Convergent brings UroAmp and proprietary urine tumor DNA technology focused on bladder cancer diagnostics to Veracyte's portfolio.
No notable change in AIR's read.
8-KFiled 14 Sep 2026Software / SaaS
Healthstream IncHSTM
8-K · Items 1.01, 2.03 — Material agreement
HealthStream amended its revolving credit facility with Truist Bank. The $50M facility matures in 2031 with unchanged terms, including a 3.00x net funded debt leverage covenant and 3.00x interest coverage ratio requirement.
No notable change in AIR's read.
10-QFiled 14 Sep 2026All industries
Value Line IncVALU
Quarterly report (10-Q), period ending 31 Jul 2026
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
8-K · Item 1.01 — Material agreement
Addus HomeCare agreed to acquire AccentCare's personal care and community care business outside New York for $275 million in cash. The transaction includes 10 operating entities across multiple states and certain assets, subject to regulatory approvals and Hart-Scott-Rodino clearance.
No notable change in AIR's read.
10-QFiled 14 Sep 2026Banks
Wealthfront CorpWLTH
Quarterly report (10-Q), period ending 31 Jul 2026
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
Bally's CorpBALY
8-K · Items 1.01, 2.03, 8.01 — Material agreement
Bally's secured $560M in senior secured term loans ($400M closing + $160M delayed draw) from WhiteHawk Capital Partners to fund pre-construction costs for the Bronx casino project and general corporate purposes. Financing expected to close Q3 2026 subject to regulatory approval.
No notable change in AIR's read.
10-KFiled 14 Sep 2026All industries
Annual report (10-K), FY2026
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
8-K · Items 1.01, 3.02, 8.01 — Material agreement
Trilogy Metals closed a ~$35.6M strategic equity investment from the U.S. Department of War, making the government an ~10% shareholder. Proceeds fund exploration and development of Alaska's Upper Kobuk Mineral Projects, advancing domestic copper supply.
No notable change in AIR's read.
8-KFiled 14 Sep 2026All industries
BKV CorpBKV
8-K · Items 1.01, 2.03, 3.02 — Material agreement
BKV issued $575M convertible senior notes due 2031 at 1.625% interest, netting ~$554.7M after fees. Proceeds allocated to capped call hedges ($64.7M), share repurchase ($35M), debt repayment, and capex.
No notable change in AIR's read.
Friday 18 Sep26 filings read · 6 material
8-KFiled 18 Sep 2026Banks
Farmers National Banc Corp /Oh/FMNB
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 18 Sep 2026Industrials
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
News CorpNWSA
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
PENTAIR plcPNR
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
Anterix Inc.ATEX
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026Banks
Burke & Herbert Financial Services Corp.BHRB
Current report (8-K)
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
Gold.com, Inc.GOLD
8-K · Items 5.02, 8.01 — Director or officer change
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
American Healthcare REIT, Inc.AHR
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
Cava Group, Inc.CAVA
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026Banks
Cleanspark, Inc.CLSK
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 18 Sep 2026Biotech
Halozyme Therapeutics, Inc.HALO
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026Industrials
Adient plcADNT
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
Iridium Communications Inc.IRDM
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
Concentrix CorpCNXC
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 18 Sep 2026Banks
Third Coast Bancshares, Inc.TCBX
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 18 Sep 2026All industries
Gold.com, Inc.GOLD
8-K · Item 4.01 — Auditor change
No notable change in AIR's read.
8-KFiled 18 Sep 2026Biotech
Theravance Biopharma, Inc.TBPH
Current report (8-K)
No notable change in AIR's read.
Thursday 17 Sep54 filings read · 10 material
8-KFiled 17 Sep 2026Industrials
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
News CorpNWSA
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
Corebridge Financial, Inc.CRBG
Current report (8-K)
No notable change in AIR's read.
8-KFiled 17 Sep 2026Biotech
Aquestive Therapeutics, Inc.AQST
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
Third Coast Bancshares, Inc.TCBX
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
First Commonwealth Financial Corp /Pa/FCF
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
Azenta, Inc.AZTA
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026Industrials
Current report (8-K)
No notable change in AIR's read.
8-KFiled 17 Sep 2026Software / SaaS
Current report (8-K)
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026Biotech
Ultragenyx Pharmaceutical Inc.RARE
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026Biotech
Current report (8-K)
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
8-K · Items 5.02, 8.01 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026Banks
Cleanspark, Inc.CLSK
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
AecomACM
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
Interparfums IncIPAR
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026Industrials
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 17 Sep 2026Biotech
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
Current report (8-K)
No notable change in AIR's read.
8-KFiled 17 Sep 2026Industrials
Anteris Technologies Global Corp.AVR
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 17 Sep 2026All industries
Current report (8-K)
No notable change in AIR's read.
Sun 22 Nov
CAPR · Capricor Therapeutics, Inc. · Regulatory date
As stated in the filing: “Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026 ●”
Announced by the company in 8-K on 10 Nov 2026
DYN · Dyne Therapeutics, Inc. · Regulatory date
As stated in the filing: “Capricor Therapeutics’ BLA for its cell therapy deramiocel is currently under FDA review with a PDUFA date of November 22, 2026.”
Announced by the company in 10-Q on 5 Nov 2026
SVRA · Savara Inc · Regulatory date
As stated in the filing: “The FDA determined that the Company’s responses to recent information requests by the Agency during its review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”
Announced by the company in 10-Q on 9 Nov 2026
Fri 27 Nov
BBIO · BridgeBio Pharma, Inc. · Regulatory date
As stated in the filing: “The first participant was dosed in ASCEND-ATTR, the Phase 3b/4 study to prospectively test disease reversal with Attruby - BBP-418 for LGMD2I/R9 has a November 27, 2026 PDUFA date, with Priority Review.”
Announced by the company in 8-K on 29 Oct 2026
Mon 30 Nov
COGT · Cogent Biosciences, Inc. · Regulatory date
As stated in the filing: “Potential FDA approval of bezuclastinib in GIST – PDUFA date of November 30, 2026 •”
Announced by the company in 8-K on 5 Nov 2026
JBIO · Jade Biosciences, Inc. · Regulatory date
As stated in the filing: “The FDA has also accepted a Biologics License Application for accelerated approval of povetacicept in IgAN, with a Prescription Drug User Fee Act target action date of November 30, 2026.”
Announced by the company in 10-Q on 13 Nov 2026
Wed 2 Dec
ARE · Alexandria Real Estate Equities, Inc. · Investor day
As stated in the filing: “We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.”
Announced by the company in 8-K on 27 Apr 2026
Thu 3 Dec
EXEL · Exelixis, Inc. · Regulatory date
As stated in the filing: “In February 2026, we announced that the FDA had accepted our NDA and assigned a standard review, with a Prescription Drug User Fee Act (PDUFA) target action date of December 3, 2026.”
Announced by the company in 10-Q on 29 Oct 2026
Tue 8 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “In addition, the Company announced that both Global Automotive and Global Industrial will host separate investor days on December 8, 2026 and December 9, 2026, respectively.”
Announced by the company in 8-K on 9 Sep 2026
LGND · Ligand Pharmaceuticals Inc · Investor day
As stated in the filing: “Ligand will provide an updated 5-year outlook during the Company’s Investor Day on December 8, 2026.”
Announced by the company in 8-K on 14 Jul 2026
Wed 9 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “Investor Days GPC and Motion will host separate investor days in New York City, with GPC’s Investor Day scheduled for December 8, 2026, and Motion’s Investor Day scheduled for December 9, 2026.”
Announced by the company in 8-K on 9 Sep 2026
Sat 12 Dec
ANAB · Anaptysbio, Inc · Regulatory date
As stated in the filing: “FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP) GSK and Tesaro Litigation Update •”
Announced by the company in 8-K on 12 Nov 2026
Thu 17 Dec
CORT · Corcept Therapeutics Inc · Regulatory date
As stated in the filing: “Relacorilant for patients with Cushing’s syndrome – Resubmitted New Drug Application Prescription Drug User Fee Act (PDUFA) date of December 17, 2026 “The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.”
Announced by the company in 8-K on 3 Nov 2026
Mon 23 Nov
MATW · Matthews International Corp · All industries
Annual results due — last year filed 21 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 30%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 0
Tue 24 Nov
BLBD · Blue Bird Corp · Industrials
Annual results due — last year filed 24 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 30%, net income up 408%
AIR's current read: News flow Balanced, Gap Very high · 82
PFLT · PennantPark Floating Rate Capital Ltd. · All industries
Annual results due — last year filed 24 Nov 2025
AIR's current read: News flow Balanced, Gap Very high · 71
Wed 25 Nov
AMTM · Amentum Holdings, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 66%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 4
ARMK · Aramark · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 6%, net income up 23%
AIR's current read: News flow Balanced, Gap Medium · 10
CASH · Pathward Financial, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 3%, net income down 31%
AIR's current read: News flow Balanced, Gap Low · 0
CLSK · Cleanspark, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue up 129%, net loss widened
AIR's current read: News flow Balanced, Gap Very high · 54
GAP · Gap Inc · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue down 7%, net income down 23%
AIR's current read: News flow Balanced, Gap Low · 3
ROAD · Construction Partners, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 28%, net income up 35%
AIR's current read: News flow Balanced, Gap Low · 7
SJM · J M SMUCKER Co · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 7
SMG · Scotts Miracle-Gro Co · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 1%, net income down 25%
AIR's current read: News flow Balanced, Gap Medium · 12
SMTC · Semtech Corp · Semiconductors
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 16%, net income up 37%
AIR's current read: News flow Balanced, Gap Low · 0
TFSL · TFS Financial CORP · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q1 2019, against a year earlier): net income up 4%
AIR's current read: News flow Balanced, Gap Medium · 23
Fri 27 Nov
ATKR · Atkore Inc. · Industrials
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 8%, net income down 98%
AIR's current read: News flow Balanced, Gap Low · 0
BJ · BJ's Wholesale Club Holdings, Inc. · All industries
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q2 2027, against a year earlier): revenue up 16%, net income up 15%
AIR's current read: News flow Balanced, Gap Medium · 18
CENT · Central Garden & Pet Co · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 8%, net income down 5%
AIR's current read: News flow Balanced, Gap Low · 1
CFFN · Capitol Federal Financial, Inc. · Banks
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2020, against a year earlier): net income down 15%
AIR's current read: News flow Balanced, Gap Medium · 10
JJSF · J&J Snack Foods Corp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 6%, net income down 20%
AIR's current read: News flow Balanced, Gap Low · 0
PD · PagerDuty, Inc. · Software / SaaS
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 1%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 0
SPH · Suburban Propane Partners Lp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue unchanged, net loss widened
AIR's current read: News flow Balanced, Gap Medium · 21
UTI · Universal Technical Institute Inc · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net income down 79%
AIR's current read: News flow Balanced, Gap Very high · 57
Mon 30 Nov
SNEX · StoneX Group Inc. · All industries
Annual results due — last year filed 28 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 15%, net income up 102%
AIR's current read: News flow Balanced, Gap Very high · 52
Tue 1 Dec
ESE · Esco Technologies Inc · Industrials
Annual results due — last year filed 1 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 14%, net income up 26%
AIR's current read: News flow Balanced, Gap Very high · 97
Wed 2 Dec
ASAN · Asana, Inc. · Software / SaaS
Quarterly results due — last year filed 2 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 10%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 0
UNFI · United Natural Foods Inc · All industries
Quarterly results due — last year filed 2 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
VSTS · Vestis Corp · All industries
Annual results due — last year filed 2 Dec 2025
Last quarter (Q3 2025, against a year earlier): revenue down 4%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 1
Thu 3 Dec
BOX · Box Inc · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 9%, net income up 43%
AIR's current read: News flow Balanced, Gap Low · 1
CRWD · CrowdStrike Holdings, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 26%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 5
HQY · Healthequity, Inc. · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 8%, net income up 10%
AIR's current read: News flow Balanced, Gap Low · 0
KSS · KOHLS Corp · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue down 5%, net income down 39%
AIR's current read: News flow Balanced, Gap Medium · 11
MEI · Methode Electronics Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
NCNO · nCino, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 11%, net income up 145%
AIR's current read: News flow Balanced, Gap Low · 5
THO · Thor Industries Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue down 8%, net income down 68%
AIR's current read: News flow Balanced, Gap Low · 4
Fri 4 Dec
AGX · Argan Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 62%, net income up 51%
AIR's current read: News flow Balanced, Gap Low · 9
AMBA · Ambarella Inc · Semiconductors
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 13%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 7
BF-B · Brown Forman Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue down 1%, net income up 4%
AIR's current read: News flow Balanced, Gap Low · 0
CXM · Sprinklr, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 1%, net income down 44%
AIR's current read: News flow Balanced, Gap Low · 9
DCI · DONALDSON Co INC · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue up 8%, net income up 13%
AIR's current read: News flow Balanced, Gap Low · 9
FIVE · Five Below, Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue up 14%, net income down 10%
AIR's current read: News flow Balanced, Gap High · 27
GWRE · Guidewire Software, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 27%, net income down 64%
AIR's current read: News flow Balanced, Gap High · 44
NTNX · Nutanix, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 10%, net income up 14%
AIR's current read: News flow Balanced, Gap Medium · 22
REX · REX AMERICAN RESOURCES Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 6%, net income up 336%
AIR's current read: News flow Balanced, Gap Low · 0
SAIC · Science Applications International Corp · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
AIR's current read: News flow Balanced, Gap High · 39
SWBI · Smith & Wesson Brands, Inc. · Industrials
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 32%, net income turned positive
AIR's current read: News flow Balanced, Gap Very high · 87
TITN · Titan Machinery Inc. · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue down 9%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 0
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Sign in to follow companies
Follow a company and its filings show up here.
Sign inResearch, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.